Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: NZ$0.03 M
• Last 3 months FTD volume: NZ$1.89 M
• Last 12 months FTD volume: NZ$4.32 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Merck MRK	NZ$33.81 M	NZ$0.17 B	🇺🇸 USA
SIGA Technologies SIGA	NZ$0.36 M	NZ$1.53 M	🇺🇸 USA
GlaxoSmithKline GSK	NZ$72.01 M	NZ$0.40 B	🇬🇧 UK
Celldex Therapeutics CLDX	NZ$7.65 M	NZ$11.96 M	🇺🇸 USA
Pfizer PFE	NZ$24.63 M	NZ$0.10 B	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	NZ$1.84 M	NZ$36.3 M	🇮🇱 Israel
Soligenix SNGX	NZ$5.86 M	NZ$13.89 M	🇺🇸 USA